Merck & Co., Inc. Debt and Lease Obligation
Merck & Co., Inc. (MRK) had Debt and Lease Obligation of $25.90 billion as of 2019-03-31, per its 10-Q filed 2019-05-08.
Discontinued › Balance Sheet › Liabilities › Debt
us-gaap:DebtAndCapitalLeaseObligations · last filed 2019-05-08
- 2019-03-31: Debt and Lease Obligation $25.90B.
- 2018-12-31: Debt and Lease Obligation $25.10B.
- 2018-09-30: Debt and Lease Obligation $23.60B.
- 2018-06-30: Debt and Lease Obligation $23.30B.
| Period end | Debt and Lease Obligation | Debt and Lease Obligation as first filed |
|---|---|---|
| 2019-03-31 | $25.90B 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $25.10B 10-Q · filed 2019-05-08 | |
| 2018-09-30 | $23.60B 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $23.30B 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $23.60B 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $24.40B 10-K · filed 2019-02-27 | |
| 2017-09-30 | $27.00B 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $24.90B 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $28.50B 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $24.80B 10-K · filed 2018-02-27 | |
| 2016-09-30 | $25.10B 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $24.30B 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $25.80B 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $26.40B 10-K · filed 2017-02-28 | $26.50B 10-K · filed 2016-02-26 |
| 2015-09-30 | $26.70B 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $26.60B 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $30.20B 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $21.40B 10-K · filed 2016-02-26 | |
| 2014-09-30 | $27.80B 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $23.10B 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $28.10B 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $25.10B 10-K · filed 2015-02-27 | |
| 2013-09-30 | $26.60B 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $28.10B 10-Q · filed 2013-08-07 | |
| 2013-03-31 | $20.80B 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $20.60B 10-K · filed 2014-02-27 | |
| 2012-09-30 | $19.60B 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $19.00B 10-Q · filed 2012-08-07 | |
| 2011-12-31 | $17.50B 10-K · filed 2013-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |